美国食品与药品管理局(FDA)精神药理学药物咨询委员会,建议FDA批准常规抗抑郁药舍曲林(sertraline)用于外伤后应激障碍的治疗。如果舍曲林能获准治疗此病,那么它将成为正式用于外伤后应激障碍治疗的首种药物。此药对男性病人的功效尚未确定。 FDA在决定是否将舍曲林的批准应用范围扩大 The FDA Advisory Committee on Psychopharmacology Drugs recommends that the FDA approve the use of sertraline, a conventional antidepressant drug, for the treatment of post-traumatic stress disorder. If sertraline is approved for treatment of the disease, it will be the first drug officially used in the treatment of post-traumatic stress disorder. The efficacy of this medicine on male patients has not been determined. The FDA is deciding whether to extend the scope of approval of sertraline